FUTTITINNI
ActiveSummary
The computed 12-month bankruptcy probability of FUTTITINNI is 1.5% (moderate). The 2025 annual accounts show equity of €24,198 and a net result of -€4,005. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 20% of 6,167 sector peers (NACE 46, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
Source: KBO- Status
- Active since 02-10-2018 Normal situation
- Registered office
- 445 active companies are registered at this address 52 started in the 12 months before. Source: KBO register, as of 2 November 2026.
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460and 2 others
- Establishment unit
- 2.280.376.760 1180 Ukkel, since 02-10-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 03-09-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.5%
- Gross margin
- €4,522
- ▼ 82.7%
- Turnover
- ≈ €44,000
- estimated
- Loss
- €4,005
- Equity
- €24,198
- ▼ 14.2%
- Total assets
- €129,363
- ▲ 211%
- Staff
- ≈ 0 FTE
- estimated
- 2025 accounts filed 38 days after the deadline
Score breakdownraises riskLast filed accounts filed 38 days late; 1 of the last 3 accounts lateLiquidity: current ratio 0.96, cash €2,923Loss of €4,005 (financial year 2025)lowers riskSize: total assets €129,363Show the evidence
Checked score
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 30% of them on solvency, 10% on liquidity, 47% on profitability and 23% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 11 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
- Caution: Less equity than 91% of companies in wholesale tradesector median €1.6m · 6,099 companies €24,198 View
Recent changes
- · Gazette deed Resignation: HAKIM MOUSSOUNI (director)
- · Gazette deed Registered office moved from Bruxelles to Uccle
- · Gazette deed Registered office moved from Brugge to BrusselResignations: Stefania Caramanna, Frederic Costenoble and Frederik Serruys · Appointments: Steve Beun (director) and Hakim Moussouni (director)
Comparable companies
These companies have the same main activity as FUTTITINNI: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €62,200 and €121,000, founded between 2016 and 2021.
| Company | Total assets | Gross margin |
|---|---|---|
| FUTTITINNI Ukkel | €129,363 | €4,522 |
| Ortho4All Oudergem | €75,019 | €9,931 |
| CONGRESS PHARMA Sint-Pieters-Woluwe | €82,571 | €11,546 |
| LAUNCHPAD EUROPE Oostkamp | €120,635 | €10,335 |
| Scientific Activities and Researches in Quality of Life Liège | €65,238 | €3,672 |
| VESALE PHARMA WOMAN HEALTH Eghezée | €62,158 | €4,327 |
| Nature Avenue Lier | €105,922 | €2,793 |
Key facts about FUTTITINNI
- What is the company number of FUTTITINNI?
- The company number of FUTTITINNI is 0707.680.227. The VAT number is the same number with BE in front: BE 0707.680.227.
- Where is FUTTITINNI based?
- The registered office is at Kersbeeklaan 308, 1180 Ukkel.Company details
- What does FUTTITINNI do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of FUTTITINNI?
- The legal form of FUTTITINNI is Private limited company (pre-2019) (BVBA).
- When was FUTTITINNI founded?
- FUTTITINNI was founded on 02-10-2018.
- Is FUTTITINNI still active?
- Yes, FUTTITINNI is an active enterprise in the KBO register.
- What is the turnover of FUTTITINNI?
- The turnover in financial year 2025 is ≈ €44,000. This figure is estimated from the gross margin of €4,522 and 69 comparable companies (NACE 464). It probably lies between €23,000 and €140,000. It is a rough estimate.Financials
- Is FUTTITINNI profitable?
- In financial year 2025, FUTTITINNI made a loss of €4,005.
- Where can I find the annual accounts of FUTTITINNI?
- FUTTITINNI filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FUTTITINNI due?
- FUTTITINNI must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.